Shady M. Abd El‐Halim

SEP 7, 2026 · JOURNAL ARTICLE

Repurposing Niflumic Acid-Loaded PEGylated Cerosomes for Topical Solid Ehrlich’s Carcinoma Management via EGFR/ERK/miR-21 Signaling Pathway Modulation

Pharmaceutics

First-in-concept preclinical study in a murine xenograft model using a novel nanoformulation; lacks human data, comparator arm, and hard clinical outcomes to support practice change.